Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors

SIMPLE SUMMARY: Chimeric antigen receptor T cells (CAR T-cells) are engineered T cells that target tumor-associated antigens. CAR T-cell therapy is a novel developed immunotherapy initially for destroying hematological malignancies. Its great success in clinical practice of hematological malignancie...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiuqiang, Lu, Lingeng, Ma, Wenxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739567/
https://www.ncbi.nlm.nih.gov/pubmed/36497465
http://dx.doi.org/10.3390/cancers14235983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739567/
https://www.ncbi.nlm.nih.gov/pubmed/36497465
http://dx.doi.org/10.3390/cancers14235983

Ejemplares similares